Veru Inc. (VERU) stock
VERUNasdaqPharmaceutical PreparationsFiscal year ends September 30
$2.14+0.06 (+2.88%)
Close on Nov 17, 2026Market cap $36.49MP/E –Yield –
Veru price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Veru's price to sales ratio was 4.8× on Jan 31, 2025, against 2.8× a year earlier. Over the last 5 years it ranged from 2.8× to 23.4×, with a median of 7.8×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2025 | Jan 31, 2025 | 4.8× | −0.8 |
| 2024 | Dec 31, 2024 | 5.6× | +1.6 |
| 2023 | Dec 29, 2023 | 4.1× | −6.7 |
| 2022 | Dec 30, 2022 | 10.8× | +3.1 |
| 2021 | Dec 31, 2021 | 7.7× | −6.5 |
| 2020 | Dec 31, 2020 | 14.2× | +7.3 |
| 2019 | Dec 31, 2019 | 6.9× | +2.0 |
| 2018 | Dec 31, 2018 | 4.9× | +0.4 |
| 2017 | Dec 29, 2017 | 4.4× | +3.2 |
| 2016 | Dec 30, 2016 | 1.2× | −0.1 |
| 2015 | Dec 31, 2015 | 1.3× | −3.3 |
| 2014 | Dec 31, 2014 | 4.6× | −3.1 |
| 2013 | Dec 31, 2013 | 7.7× | +1.9 |
| 2012 | Dec 31, 2012 | 5.9× | −1.0 |
| 2011 | Oct 31, 2011 | 6.8× | −0.2 |
| 2010 | Dec 31, 2010 | 7.0× | +2.3 |
| 2009 | Dec 31, 2009 | 4.8× | – |
See a number that looks wrong?